Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer. Kang J, Deng QM, Feng W, Chen ZH, et al. Lung Cancer 2023;178:66-74.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kang J, Deng QM, Feng W, Chen ZH, et al. Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer. Lung Cancer 2023;178:66-74.
PMID: 36806896